Viewing Study NCT05177133


Ignite Creation Date: 2025-12-25 @ 2:52 AM
Ignite Modification Date: 2026-03-02 @ 4:11 AM
Study NCT ID: NCT05177133
Status: RECRUITING
Last Update Posted: 2024-08-02
First Post: 2021-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus)
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module